Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company founded in 2015 with the goal of developing best-in-class molecules and combination therapies for people with cancer. It describes itself as being at the forefront of designing combination therapies, with discovery capabilities producing differentiated small molecules and antibodies designed to optimize combinability, and accelerated development guided by specific biologic mechanisms of cancer.

Arcus Biosciences was founded in 2015. Terry Rosen, PhD, and Juan Jaen, PhD, co-founded Arcus in 2015 as a drug discovery company focused on the treatment of cancer by blocking tumor-induced immunosuppression. The company describes itself as a highly productive, clinical-stage, global biopharmaceutical company with the goal of developing best-in-class molecules and combination therapies for people with cancer.

At the forefront of designing combination therapies, with best-in-class potential, in the relentless pursuit of cures for cancer.

• Unconfirmed

  Reported2020.05.28

  Gilead and Arcus sign oncology collaboration deal[6]Gilead与Arcus签署肿瘤合作协议pharmaceutical-business-review.com

  Gilead Sciences signed a 10-year collaboration deal with Arcus Biosciences to co-develop and co-commercialise current and future cancer therapeutic candidates in Arcus's pipeline. The deal is valued at up to $1.97 billion.

Read more

1. 1Arcus Biosciences | Pursuit of Cures for Cancerarcusbio.com
2. 2About Us | Arcus Biosciencesarcusbio.com
3. 3Leadership Team | Arcus Biosciencesarcusbio.com
4. 4Contact Us | Arcus Biosciencesarcusbio.com
5. 5Arcus Bioscienceswikidata.org
6. 6Gilead与Arcus签署肿瘤合作协议pharmaceutical-business-review.com